Aldose reductase deficiency protects sugar-induced lens opacification in rats
- PMID: 21376710
- PMCID: PMC3103638
- DOI: 10.1016/j.cbi.2011.02.028
Aldose reductase deficiency protects sugar-induced lens opacification in rats
Abstract
Aldose reductase (AKR1B1), which catalyzes the reduction of glucose to sorbitol and lipid aldehydes to lipid alcohols, has been shown to be involved in secondary diabetic complications including cataractogenesis. Rats have high levels of AKR1B1 in lenses and readily develop diabetic cataracts, whereas mice have very low levels of AKR1B1 in their lenses and are not susceptible to hyperglycemic cataracts. Studies with transgenic mice that over-express AKR1B1 indicate that it is the key protein for the development of diabetic complications including diabetic cataract. However, no such studies were performed in genetically altered AKR1B1 rats. Hence, we developed siRNA-based AKR1B1 knockdown rats (ARKO) using the AKR1B1-siRNA-pSuper vector construct. Genotyping analysis suggested that more than 90% of AKR1B1 was knocked down in the littermates. Interestingly, all the male animals were born dead and only 3 female rats survived. Furthermore, all 3 female animals were not able to give birth to F1 generation. Hence, we could not establish an AKR1B1 rat knockdown colony. However, we examined the effect of AKR1B1 knockdown on sugar-induced lens opacification in ex vivo. Our results indicate that rat lenses obtained from AKR1B1 knockdown rats were resistant to high glucose-induced lens opacification as compared to wild-type (WT) rat lenses. Biochemical analysis of lens homogenates showed that the AKR1B1 activity and sorbitol levels were significantly lower in sugar-treated AKR1B1 knockdown rat lenses as compared to WT rat lenses treated with 50mM glucose. Our results thus confirmed the significance of AKR1B1 in the mediation of sugar-induced lens opacification and indicate the use of AKR1B1 inhibitors in the prevention of cataractogenesis.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Figures



Similar articles
-
Aldose reductase expression as a risk factor for cataract.Chem Biol Interact. 2015 Jun 5;234:247-53. doi: 10.1016/j.cbi.2014.12.017. Epub 2014 Dec 22. Chem Biol Interact. 2015. PMID: 25541468 Free PMC article.
-
Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.J Ocul Pharmacol Ther. 2000 Apr;16(2):149-60. doi: 10.1089/jop.2000.16.149. J Ocul Pharmacol Ther. 2000. PMID: 10803425
-
Levels of expression of hexokinase, aldose reductase and sorbitol dehydrogenase genes in lens of mouse and rat.Curr Eye Res. 1993 Apr;12(4):323-32. doi: 10.3109/02713689308999456. Curr Eye Res. 1993. PMID: 8319491
-
Aldose reductase: a window to the treatment of diabetic complications?Prog Retin Eye Res. 1998 Jul;17(3):313-83. doi: 10.1016/s1350-9462(97)00013-x. Prog Retin Eye Res. 1998. PMID: 9695797 Review.
-
Diabetic and galactosaemic cataracts.Ciba Found Symp. 1984;106:110-31. doi: 10.1002/9780470720875.ch7. Ciba Found Symp. 1984. PMID: 6439498 Review.
Cited by
-
Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.Sci Rep. 2019 Oct 11;9(1):14684. doi: 10.1038/s41598-019-51059-2. Sci Rep. 2019. PMID: 31604989 Free PMC article.
-
Computation Screening of Multi-Target Antidiabetic Properties of Phytochemicals in Common Edible Mediterranean Plants.Plants (Basel). 2022 Jun 21;11(13):1637. doi: 10.3390/plants11131637. Plants (Basel). 2022. PMID: 35807588 Free PMC article.
-
Preventive effect of Zea mays L. (purple waxy corn) on experimental diabetic cataract.Biomed Res Int. 2014;2014:507435. doi: 10.1155/2014/507435. Epub 2014 Jan 16. Biomed Res Int. 2014. PMID: 24527449 Free PMC article.
-
Network Pharmacology-Based Strategy to Reveal the Mechanism of Cassiae Semen against Cataracts.Comput Math Methods Med. 2022 Jul 11;2022:5654120. doi: 10.1155/2022/5654120. eCollection 2022. Comput Math Methods Med. 2022. PMID: 35860180 Free PMC article.
-
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers.Front Pharmacol. 2012 Jun 6;3:104. doi: 10.3389/fphar.2012.00104. eCollection 2012. Front Pharmacol. 2012. PMID: 22685431 Free PMC article.
References
-
- Hers HG. The mechanism of the transformation of glucose in fructose in the seminal vesicles. Biochim Biophys Acta. 1956;22:202–203. - PubMed
-
- Bhatnagar A, Srivastava SK. Biochemical aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Med. Metab. Biol. 1992;48:91–121. - PubMed
-
- Dyck PJ, Thomas PK. Diabetic Neuropathy. W. B Saunders; Philadelphia: 1999.
-
- Brownlee M. Biochemistry and molecular biology of diabetic complications. Nature. 2001;414:813–820. - PubMed
-
- Beckman JA, Creager MA, Libby P. Diabetic and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–2581. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials